MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13104-026-07781-y

Медицинская библиотека · BMC research notes · 2026

Subtherapeutic exposure in doxorubicin pharmacokinetics among Ugandan breast cancer patients: a pilot study with implications for personalized therapy.

Darshit Dave, Godfrey Osinde, Sekaggya-Wiltshire Christine, Jackson Mukonzo, Karyaburo Ronald Kadada, Buzibye Allan, Omali Denis, Niyonzima Nixon, Srikant Sanjanaa, Dave Dhara

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Breast cancer remains a major cause of morbidity and mortality among Ugandan women, who often present at younger age with advanced disease. Doxorubicin is central to treatment regimens, but current dosing is adapted without validation in this setting. We conducted the first pilot prospective pharmacokinetic study among 21 breast cancer women at Uganda Cancer Institute.

RESULTS

Participants received doxorubicin (60 mg/m²) intravenously over 30 min. Samples were collected at pre-infusion, 4- and 24-hours post-infusion. Plasma concentrations were quantified using HPLC-UV and non-compartmental PK analysis was performed in R (Xgxr-v1.1.4). The mean age was 45 ± 12 years and 81% presented with metastatic disease. At 4 h, mean plasma concentration was 15.45 ± 10.97 ng/mL (CV: 71%; 95% CI: 10.46–20.44), declining to 6.58 ± 4.17 ng/mL (CV: 63%; 95% CI: 4.68–8.48) at 24 h. The mean AUC0–24 was 251.16 ± 151.14 ngh/mL (CV: 60%; 95% CI: 182.36–319.96). Our study suggests lower early systemic exposure, potentially reducing therapeutic efficacy. The high prevalence of advanced-stage disease underscores diagnostic delays and poor prognosis. These preliminary findings warrant larger PK studies integrating genetics and clinical outcomes to validate and extend our hypothesis-generating observations to guide treatment in this setting.

Для цитирования: Darshit Dave, Godfrey Osinde, Sekaggya-Wiltshire Christine, Jackson Mukonzo, Karyaburo Ronald Kadada, Buzibye Allan, Omali Denis, Niyonzima Nixon, Srikant Sanjanaa, Dave Dhara. Subtherapeutic exposure in doxorubicin pharmacokinetics among Ugandan breast cancer patients: a pilot study with implications for personalized therapy.. BMC research notes. 2026. DOI: 10.1186/s13104-026-07781-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.